Skip to content
Screener

MapLight Therapeutics, Inc. MPLT Professional Fees — General And Administrative Expense

Other segment segments

Employee Related
$6.99M+239%

Similar metrics at other companies

Rein Therapeutics Inc. logo
RNTXProfessional Fees For Services — General And Administrative Expense
$790K-30.6%
Beam Therapeutics logo
BEAMExternal General And Administrative Expenses — General And Administrative Expense
$13.37M+149%
Solid Biosciences Inc. logo
SLDBExternal General And Administrative Expense — General And Administrative Expense
$6.33M+19.9%
Solid Biosciences Inc. logo
SLDBInternal General And Administrative Expense — General And Administrative Expense
$4.73M+40.9%
TRA
TRAXExternal Expenses — General And Administrative Expense
$8.72M+127%
AnaptysBio, Inc. logo
ANABExternal Expenses — General And Administrative Expense
$12.12M+119%

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%
Total assets$418.8M

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$552.31M-20.4%
Enterprise value$502.19M

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio22.9×

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The source filing: MapLight Therapeutics, Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:25 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-224129
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Employee-related research and development expenses15,9937,050
Chemistry, manufacturing and controls expenses6,4173,956
Preclinical program expenses5,5226,081
Other research and development expenses933761
Employee-related general and administrative expenses6,9902,060
Professional fees and other general and administrative expenses3,8291,696
Other segment items(1)(3,835)(1,203)
Net loss$60,668$22,340

Item 1. Financial Statements.

FAQ

What is MapLight Therapeutics, Inc.'s professional fees — general and administrative expense?
MapLight Therapeutics, Inc. (MPLT) reported professional fees — general and administrative expense of $3.83M in Q1 2026.
How has MapLight Therapeutics, Inc.'s professional fees — general and administrative expense changed year-over-year?
MapLight Therapeutics, Inc.'s professional fees — general and administrative expense increased by 125.8% year-over-year, from $1.7M to $3.83M.
What does professional fees — general and administrative expense mean?
This metric represents the portion of general and administrative expenses specifically allocated to professional services, such as legal, consulting, accounting, and advisory fees. It reflects the company's investment in external expertise required to support corporate operations, regulatory compliance, and strategic initiatives. Monitoring this expense helps assess the efficiency of administrative overhead and the reliance on third-party professional support in managing business operations.

Ask your AI about MapLight Therapeutics, Inc.'s professional fees — general and administrative expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude